Industry Research Reports
Home > Reports > Medical Devices & Consumables > Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-01-19
Pages: 88 Pages
Report ld: 5728030
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
The North American market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market include Medtronic, Jiuyuan Gene Engineering, Cellumed, Yantai Zhenghai Bio-Tech, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2), covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2).
MARKET SEGMENTATION
By Company
- Medtronic
- Jiuyuan Gene Engineering
- Cellumed
- Yantai Zhenghai Bio-Tech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Sponge Carrier
- Hydroxyapatite Carrier
Segment by Application
- Spinal Fusion
- Trauma Surgery
- Oral Maxillofacial Surgery
- Reconstructive
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Introduction
1.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size Forecast
1.2.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (2021–2032)
1.2.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume (2021–2032)
1.2.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Price (2021–2032)
1.3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Trends & Drivers
1.3.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Industry Trends
1.3.2 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Drivers & Opportunities
1.3.3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Challenges
1.3.4 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Players Revenue Ranking (2025)
2.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Revenue by Company (2021–2026)
2.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume Ranking of Players (2025)
2.4 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Company (2021–2026)
2.5 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Company (2021–2026)
2.6 Key Manufacturers Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Manufacturing Base and Headquarters
2.7 Key Manufacturers Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Offerings
2.8 Key Manufacturers Start of Mass Production of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2)
2.9 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Competitive Analysis
2.9.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Classification
3.1 Introduction by Type
3.1.1 Sponge Carrier
3.1.2 Hydroxyapatite Carrier
3.1.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type
3.1.3.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, by Type (2021–2032)
3.1.3.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, by Type (%), 2021–2032
3.1.4 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Type
3.1.4.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume, by Type (2021–2032)
3.1.4.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume, by Type (%), 2021–2032
3.1.5 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Spinal Fusion
4.1.2 Trauma Surgery
4.1.3 Oral Maxillofacial Surgery
4.1.4 Reconstructive
4.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application
4.2.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, by Application (2021–2032)
4.2.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, by Application (%), 2021–2032
4.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Application
4.3.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume, by Application (2021–2032)
4.3.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume, by Application (%), 2021–2032
4.4 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region
5.1.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region (2021–2026)
5.1.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region (2027–2032)
5.1.4 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region (%), 2021–2032
5.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region
5.2.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region (2021–2026)
5.2.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region (2027–2032)
5.2.4 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region (%), 2021–2032
5.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
5.4.2 North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
5.5.2 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
5.6.2 Asia Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
5.7.2 South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
5.8.2 Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value and Sales Volume
6.2.1 Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
6.2.2 Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
6.3.2 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
6.4.2 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
6.5.2 China Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
6.5.3 China Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
6.6.2 Japan Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
6.7.2 South Korea Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
6.8.2 Southeast Asia Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021–2032
6.9.2 India Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
6.9.3 India Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Medtronic Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Offerings
7.1.5 Medtronic Recent Developments
7.2 Jiuyuan Gene Engineering
7.2.1 Jiuyuan Gene Engineering Company Information
7.2.2 Jiuyuan Gene Engineering Introduction and Business Overview
7.2.3 Jiuyuan Gene Engineering Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Jiuyuan Gene Engineering Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Offerings
7.2.5 Jiuyuan Gene Engineering Recent Developments
7.3 Cellumed
7.3.1 Cellumed Company Information
7.3.2 Cellumed Introduction and Business Overview
7.3.3 Cellumed Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Cellumed Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Offerings
7.3.5 Cellumed Recent Developments
7.4 Yantai Zhenghai Bio-Tech
7.4.1 Yantai Zhenghai Bio-Tech Company Information
7.4.2 Yantai Zhenghai Bio-Tech Introduction and Business Overview
7.4.3 Yantai Zhenghai Bio-Tech Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Yantai Zhenghai Bio-Tech Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Offerings
7.4.5 Yantai Zhenghai Bio-Tech Recent Developments
8 Industry Chain Analysis
8.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Industrial Chain
8.2 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Model
8.5.2 Sales Channels
8.5.3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Trends
Table 2. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Drivers & Opportunities
Table 3. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Challenges
Table 4. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Restraints
Table 5. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Revenue by Company (US$ Million), 2021–2026
Table 6. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Revenue Market Share by Company (2021–2026)
Table 7. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Company (K Units), 2021–2026
Table 8. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Price by Company (US$/Unit), 2021–2026
Table 10. Key Manufacturers Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Manufacturing Base and Headquarters
Table 11. Key Manufacturers Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Type
Table 12. Key Manufacturers Start of Mass Production of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2)
Table 13. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Share in Value by Type (2021–2026)
Table 20. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Share in Value by Type (2027–2032)
Table 21. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Type (K Units), 2021–2026
Table 23. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Type (K Units), 2027–2032
Table 24. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Price by Type (US$/Unit), 2021–2026
Table 27. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Price by Type (US$/Unit), 2027–2032
Table 28. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Share in Value by Application (2021–2026)
Table 32. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Share in Value by Application (2027–2032)
Table 33. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
Table 34. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Application (K Units), 2021–2026
Table 35. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Application (K Units), 2027–2032
Table 36. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Price by Application (US$/Unit), 2021–2026
Table 39. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Price by Application (US$/Unit), 2027–2032
Table 40. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region (%), 2021–2026
Table 44. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region (%), 2027–2032
Table 45. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
Table 46. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region (K Units), 2021–2026
Table 47. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region (K Units), 2027–2032
Table 48. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region (%), 2021–2026
Table 49. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Region (%), 2027–2032
Table 50. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Region (US$/Unit), 2021–2026
Table 51. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Price by Region (US$/Unit), 2027–2032
Table 52. Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume, (K Units), 2021–2026
Table 56. Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume, (K Units), 2027–2032
Table 57. Medtronic Company Information
Table 58. Medtronic Introduction and Business Overview
Table 59. Medtronic Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 60. Medtronic Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Offerings
Table 61. Medtronic Recent Developments
Table 62. Jiuyuan Gene Engineering Company Information
Table 63. Jiuyuan Gene Engineering Introduction and Business Overview
Table 64. Jiuyuan Gene Engineering Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 65. Jiuyuan Gene Engineering Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Offerings
Table 66. Jiuyuan Gene Engineering Recent Developments
Table 67. Cellumed Company Information
Table 68. Cellumed Introduction and Business Overview
Table 69. Cellumed Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 70. Cellumed Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Offerings
Table 71. Cellumed Recent Developments
Table 72. Yantai Zhenghai Bio-Tech Company Information
Table 73. Yantai Zhenghai Bio-Tech Introduction and Business Overview
Table 74. Yantai Zhenghai Bio-Tech Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 75. Yantai Zhenghai Bio-Tech Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Offerings
Table 76. Yantai Zhenghai Bio-Tech Recent Developments
Table 77. Key Raw Materials Lists
Table 78. Key Suppliers of Raw Materials Lists
Table 79. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Downstream Customers
Table 80. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Distributors List
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Picture
Figure 2. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 4. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume (K Units), 2021–2032
Figure 5. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Price (US$/Unit), 2021–2032
Figure 6. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Report Years Considered
Figure 7. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume Ranking of Players (K Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Revenue in 2025
Figure 10. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Sponge Carrier Picture
Figure 12. Hydroxyapatite Carrier Picture
Figure 13. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
Figure 16. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Price by Type (US$/Unit), 2021–2032
Figure 18. Product Picture of Spinal Fusion
Figure 19. Product Picture of Trauma Surgery
Figure 20. Product Picture of Oral Maxillofacial Surgery
Figure 21. Product Picture of Reconstructive
Figure 22. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value Market Share by Application, 2025 & 2032
Figure 24. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
Figure 25. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume Market Share by Application, 2025 & 2032
Figure 26. Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Price by Application (US$/Unit), 2021–2032
Figure 27. North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 28. North America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Country (%), 2025 vs 2032
Figure 29. Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 30. Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Country (%), 2025 vs 2032
Figure 31. Asia Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 32. Asia Pacific Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Region (%), 2025 vs 2032
Figure 33. South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 34. South America Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Country (%), 2025 vs 2032
Figure 35. Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 36. Middle East & Africa Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Country (%), 2025 vs 2032
Figure 37. Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (%), 2021–2032
Figure 38. Key Countries/Regions Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Volume (%), 2021–2032
Figure 39. United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 40. United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
Figure 41. United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (%), 2025 vs 2032
Figure 42. Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 43. Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
Figure 44. Europe Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (%), 2025 vs 2032
Figure 45. China Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 46. China Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
Figure 47. China Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (%), 2025 vs 2032
Figure 48. Japan Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 49. Japan Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
Figure 50. Japan Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (%), 2025 vs 2032
Figure 51. South Korea Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 52. South Korea Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
Figure 53. South Korea Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (%), 2025 vs 2032
Figure 54. Southeast Asia Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 55. Southeast Asia Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
Figure 56. Southeast Asia Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (%), 2025 vs 2032
Figure 57. India Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value (US$ Million), 2021–2032
Figure 58. India Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Type (%), 2025 vs 2032
Figure 59. India Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Value by Application (%), 2025 vs 2032
Figure 60. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Industrial Chain
Figure 61. Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market?
The top companies in the global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market are Medtronic、Jiuyuan Gene Engineering、Cellumed.
Related Reports
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 110
USD 4900.00
(Single User License)
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 67
USD 4250.00
(Single User License)
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Research Report 2026
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 96
USD 2900.00
(Single User License)
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 126
USD 4900.00
(Single User License)
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 72
USD 4250.00
(Single User License)
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 83
USD 3950.00
(Single User License)
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Research Report 2025
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 71
USD 2900.00
(Single User License)
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Insights, Forecast to 2030
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published Date: 2024-06-15
Pages: 125
USD 4900.00
(Single User License)
Global and United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Report & Forecast 2024-2030
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published Date: 2024-06-15
Pages: 93
USD 4350.00
(Single User License)
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Research Report 2024
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published Date: 2024-06-15
Pages: 77
USD 2900.00
(Single User License)
Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 110
USD 4900.00 (Single User License)Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 67
USD 4250.00 (Single User License)Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Research Report 2026
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 96
USD 2900.00 (Single User License)Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 126
USD 4900.00 (Single User License)Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 72
USD 4250.00 (Single User License)Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 83
USD 3950.00 (Single User License)Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Research Report 2025
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 71
USD 2900.00 (Single User License)Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Insights, Forecast to 2030
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published: 2024-06-15
Pages: 125
USD 4900.00 (Single User License)Global and United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Report & Forecast 2024-2030
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published: 2024-06-15
Pages: 93
USD 4350.00 (Single User License)Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Research Report 2024
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published: 2024-06-15
Pages: 77
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now